<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="letter" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cytogenet</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Cytogenet</journal-id>
<journal-title-group>
<journal-title>Molecular Cytogenetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1755-8166</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27516809</article-id>
<article-id pub-id-type="pmc">4980801</article-id>
<article-id pub-id-type="publisher-id">272</article-id>
<article-id pub-id-type="doi">10.1186/s13039-016-0272-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromosomal microarray analysis as the first-tier test for the identification of pathogenic copy number variants in chromosome 9 pericentric regions and its challenge</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1095-1091</contrib-id>
<name>
<surname>Wang</surname>
<given-names>Jia-Chi</given-names>
</name>
<address>
<phone>949-728-4336</phone>
<email>jia-chi.j.wang@questdiagnostics.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boyar</surname>
<given-names>Fatih Z.</given-names>
</name>
<address>
<phone>1-949-728- 4035</phone>
<email>Fatih.Z.Boyar@QuestDiagnostics.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1">Cytogenetics Laboratory, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA 92690 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>10</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>9</volume>
<elocation-id>64</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>7</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Chromosomal microarray analysis (CMA) has been recommended and practiced routinely in the large reference laboratories of U.S.A. as the first-tier test for the postnatal evaluation of individuals with intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies. Using CMA as a diagnostic tool and without a routine setting of fluorescence in situ hybridization with labeled bacterial artificial chromosome probes (BAC-FISH) in the large reference laboratories becomes a challenge in the characterization of chromosome 9 pericentric region. This region has a very complex genomic structure and contains a variety of heterochromatic and euchromatic polymorphic variants. These variants were usually studied by G-banding, C-banding and BAC-FISH analysis. Chromosomal microarray analysis (CMA) was not recommended since it may lead to false positive results. Here, we presented a cohort of four cases, in which high-resolution CMA was used as the first-tier test or simultaneously with G-banding analysis on the proband to identify pathogenic copy number variants (CNVs) in the whole genome. CMA revealed large pathogenic CNVs from chromosome 9 in 3 cases which also revealed different G-banding patterns between the two chromosome 9 homologues. Although we demonstrated that high-resolution CMA played an important role in the identification of pathogenic copy number variants in chromosome 9 pericentric regions, the lack of BAC-FISH analysis or other useful tools renders significant challenges in the characterization of chromosome 9 pericentric regions.</p>
<p><bold>Trial registration:</bold> None; it is not a clinical trial, and the cases were retrospectively collected and analyzed.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s13039-016-0272-6) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Chromosome 9</kwd>
<kwd>Euchromatic variants</kwd>
<kwd>First-tier test</kwd>
<kwd>Heterochromatic variants</kwd>
<kwd>Interstitial deletion</kwd>
<kwd>Interstitial duplication</kwd>
<kwd>Pericentric inversion</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Headings</title>
<p>CMA as the first-tier test for the identification of pathogenic CNVs in chromosome 9 pericentric regions and its challenge.</p>
</sec>
<sec id="Sec2">
<title>Letter to the Editors</title>
<p>Chromosomal microarray analysis (CMA) has been recommended as the first-tier test for the postnatal evaluation of individuals with intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies since 2010 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], and was later confirmed by other group [<xref ref-type="bibr" rid="CR3">3</xref>]. This practice has become a standard for the large reference laboratories in U.S.A after the American College of Medical Genetics (ACMG) published the professional guidelines [<xref ref-type="bibr" rid="CR4">4</xref>]. In these laboratories, CMA has largely replaced fluorescence in situ hybridization (FISH) analysis for the identification of pathogenic copy number variants (CNVs) across the whole genome.</p>
<p>Chromosome 9 pericentric regions have been known to contain a very complex genomic structure because of the presence of a huge amount of heterochromatin and large tracks of segmentally duplicated euchromatin [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The segmentally duplicated sequences predispose and mediate the generation of deletion, duplication, insertion, triplication and amplification variants within the pericentric regions of chromosome 9 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. In a cohort of 334 carriers studied by using FISH analysis with different sets of labeled bacterial artificial chromosome (BAC) probes (BAC-FISH), 17 different types of heterochromatic variants of chromosome 9 have been identified [<xref ref-type="bibr" rid="CR6">6</xref>], with pericentric inversions being the most frequent variant (50 %) followed by 9qh-variants (24 %) and 9ph-variants (11 %). Additionally, four different types of euchromatic variants have been detected: (1) 9p12 amplification variant [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], (2) 9q12 insertion variant [<xref ref-type="bibr" rid="CR5">5</xref>], (3) 9q21 deletion variant [<xref ref-type="bibr" rid="CR5">5</xref>], and (4) 9q21 amplification variant [<xref ref-type="bibr" rid="CR7">7</xref>]. Because of the presence of repetitive sequences, chromosomal microarray analysis (CMA) was not recommended to be utilized since it may lead to false positive results [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p>For this reason, we retrospectively reviewed our postnatal database to search interesting cases with CNVs in chromosome 9. High-resolution CMA was either used as the first-tier test or simultaneously ordered with G-banding analysis. For G-banding, peripheral blood was cultured for 72 h in RPMI-1640 medium. Metaphase chromosomes were analyzed using standard G-banding techniques. CMA was performed using genomic DNA extracted from uncultured whole blood on the oligo-SNP array (CytoScan HD<sup>®</sup>, Affymetrix). Hybridization, data extraction and analysis were performed as per manufacturer’s protocols. The Affymetrix<sup>®</sup> Chromosome Analysis Suite (ChAS) Software version 2.0 was used for data analysis, review and reporting. For chromosome 9, the probes from CytoScan HD<sup>®</sup> covered the following genomic regions: 9p (chr9:192,129–40,784,142, 43,400,082–44,900,526) and 9q (chr9:66,837,485–141,025,328). Thresholds are set at &gt;200 kb for gains, &gt;50 kb for losses for genome-wide region, and at &gt;100 kb for gains, &gt;20 kb for losses for cytogenetic relevant regions. Genomic coordinates are based upon genome build 37/hg19 (2009).</p>
<p>Patient 1 was a newborn girl who was referred to rule out a chromosomal anomaly. Using G-banding, it was initially reported as a common chromosome 9 normal pericentric inversion variant, 46,XX,inv(9)(p13q21.11), with a morphology similar to inv(9)(var2) in the previous report [<xref ref-type="bibr" rid="CR6">6</xref>]. The second reviewer thought it was a large pericentric inversion, 46,XX,inv(9)(p13q32) since the band 9q31 was missing (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>, arrow) and instead inverted to 9p13 region (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>, arrow head), and considered that it was not a variant. Further characterization of this large pericentric inversion by concurrent high-resolution CMA revealed the presence of an interstitial deletion of 14 Mb at 9q22.3–q32 (chr9:104,382,544–118,273,644; hg19; Fig. <xref ref-type="fig" rid="Fig1">1b</xref>; the genes involved were listed in the Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). The revised karyotype was 46,XX,del(9)(q22.3q32)inv(9)(p13q21.11). It was concluded that two chromosomal rearrangements have occurred to the same chromosome 9: a polymorphic pericentric inversion and an interstitial deletion of 9q22.3–q32. It is actually very difficult to distinguish between the deletion of 9q22–q32 and 9q32–q34 without using molecular cytogenetic methods [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Usually the patients with interstitial deletions involving 9q22 had a loss of the <italic>PTCH1</italic> gene (chr9: 98,205,265–98,279,247), and thus revealed typical features of Gorlin syndrome [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. However, since the deletion in this patient was distal to the <italic>PTCH1</italic> gene, this newborn girl did not have Gorlin syndrome.<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> G-banding analysis of patient 1 revealed a pericentric inversion of chromosome 9; the missing band 9q31 (<italic>arrow</italic>) was initially considered to be inverted to 9p13 region (<italic>arrow head</italic>); <bold>b</bold> CMA identified a pathogenic interstitial deletion of 14 Mb at 9q22.3-q32 (chr9:104,382,544–118,273,644; hg19); <bold>c</bold> G-banding analysis of patient 2 revealed an extra band at 9qh; <bold>d</bold> CMA identified a pathogenic gain of 6.3 Mb from 9q21.33–q22.31 (chr9:90,118,500–96,395,801); <bold>e</bold> G-banding analysis of patient 3 revealed an extra band at the 9q22.1 region; <bold>f</bold> CMA identified a 10.4 Mb pathogenic gain from 9q21.31–q22.2 (chr9:82,745,056–93,173,691); <bold>g</bold> G-banding analysis of patient 4 revealed an extra band at 9q12 region with a morphology similar to that of patient 2; <bold>h</bold> CMA did not reveal copy number changes, which ruled out the presence of pathogenic variants</p></caption><graphic id="MO1" xlink:href="13039_2016_272_Fig1_HTML"></graphic></fig></p>
<p>Patient 2 was a 2-year-old girl with developmental delay, lack of coordination, mixed receptive expressive language disorder and convulsion. It was initially considered as a chromosome 9 euchromatic variant with an extra G-dark band within the proximal 9q heterochromatin region or it could be an insertion or duplication from 9q13–q21.1 (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>, arrow). The C-banding was negative. This type of euchromatic variant has been reported in several cases [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] and classified as one of the four major categories of euchromatic variant [<xref ref-type="bibr" rid="CR7">7</xref>]. The high-resolution CAM that was simultaneously performed, however, showed a genomic gain of 6.3 Mb from 9q21.33–q22.31 (chr9:90,118,500–96,395,801; hg19; Fig. <xref ref-type="fig" rid="Fig1">1d</xref>; genes involved listed in the Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). This case was an excellent example of how CMA analysis showed that an extra G-dark band in proximal 9q was a pathogenic duplication of proximal 9q rather than a euchromatic variant. This gain did not include the <italic>PTCH1</italic> gene (located at chr9: 98,205,265–98,279,247) and, thus the phenotype was different from the previously reported familial cases with 9q22.3 microduplication spanning <italic>PTCH1</italic> [<xref ref-type="bibr" rid="CR17">17</xref>], and without microcephaly or holoprosencephaly that were often seen in patients with gain of <italic>PTCH1</italic> [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
<p>Patient 3 was a 24-year-old woman referred to rule out a chromosomal disorder with reported family history of a chromosome 9 abnormality. G-banding analysis considered it was an insertion of an extra band to the 9q22 region (Fig. <xref ref-type="fig" rid="Fig1">1e</xref>). CMA revealed it was a duplication of 10.4 Mb from 9q21.31-q22.2 (chr9:82,745,056–93,173,691; Fig. <xref ref-type="fig" rid="Fig1">1f</xref>; genes involved listed in the Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). Duplication of 9q21.2–q22.3 was reported in a 2-year-old female with growth and motor retardation and in her aunt without apparent phenotypic anomalies [<xref ref-type="bibr" rid="CR19">19</xref>], and a more distal duplication of 9q22.31–q22.32 was associated with congenital diaphragmatic hernia [<xref ref-type="bibr" rid="CR20">20</xref>]. Our patient was not known to have these anomalies.</p>
<p>Patient 4 was a 10-year-old boy with failure to thrive and cognitive deficits. G-banding analysis revealed an extra band at 9q12 region (Fig. <xref ref-type="fig" rid="Fig1">1g</xref>), and C-banding was positive (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S1). CMA did not reveal copy number variants (Fig. <xref ref-type="fig" rid="Fig1">1h</xref>) since the probes from the CMA apparently did not cover the repetitive sequences. The G-positive and C-positive extra band in this case was concluded as a rare heterochromatic variant [<xref ref-type="bibr" rid="CR6">6</xref>], instead of a G-positive and C-negative euchromatic variant [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p>The four cases described here demonstrate how CMA characterize the chromosome 9 pericentric regions along with G-banding and/or C-banding without access to BAC-FISH analysis. Patient 1 was a very rare case with the presence of an interstitial deletion which coexisted with a polymorphic pericentric inversion. Patient 2 was an excellent example of how CMA differentiated a pathogenic gain from a heterochromatic variant as observed in patient 4. In patient 3, CMA revealed it was a likely pathogenic duplication although previous report showed a reduced penetrance in one family study [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p>Although we demonstrated that high-resolution CMA played an important role in the identification of pathogenic copy number variants in chromosome 9 pericentric regions, the lack of BAC-FISH analysis as a routine setting in the large reference laboratory renders significant challenges in further characterization of chromosome 9 variants. The major advantage of using CMA as the first-tier test is to detect pathogenic CNVs across the whole genome including chromosome 9. However, when a huge amount of heterochromatin and large tracks of segmentally duplicated euchromatin are present in chromosome 9 pericentric regions, CMA was unable to differentiate tandem, inverted and insertional duplication, or to confirm pericentric inversion. Our cohort supported using CMA as first-tier test when chromosomal disorders were indicated to rule out the presence of pathogenic copy number variants, and using BAC-FISH analysis to further evaluate heterochromatic and euchromatic variants of chromosome 9.</p>
</sec>
<sec id="Sec3">
<title>Abbreviations</title>
<p>BAC, bacterial artificial chromosome; CMA, chromosomal microarray analysis; FISH, fluorescence in situ hybridization</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec4">
<title>Additional files</title>
<p>
<media id="MOESM1" position="anchor" xlink:href="13039_2016_272_MOESM1_ESM.doc">
<label>Additional file 1: Table S1.</label>
<caption>
<p>List of genes that are involved in the CNVs of case 1-3. (DOC 32 kb)</p>
</caption>
</media>
<media id="MOESM2" position="anchor" xlink:href="13039_2016_272_MOESM2_ESM.jpg">
<label>Additional file 2: Figure S1.</label>
<caption>
<p>The extra G-positive band was most likely C-positive by C-banding analysis (arrow) in one chromosome 9 homologue, which indicated that the extra band was heterochromatin in origin. The other chromosome 9 homologue also showed a large amount of heterochromatin (arrow head). The C-banding result was not 100 % conclusive, and thus using BAC-FISH with proper probes will be able to confirm this result. (JPG 28 kb)</p>
</caption>
</media>
</p>
</sec>
</app>
</app-group>
<ack>
<title>Acknowledgements</title>
<p>The authors acknowledge that Andrew Hellman and Jeff Radcliff provided valuable assistance in manuscript revisions.</p>
<sec id="FPar1">
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>The raw data and materials used for this study have been de-identified and were freely available to any scientist wishing to use them without breaching participant confidentiality.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>JCW- reviewing, analysis and interpretation of the data, drafting and revising the article, final approval of the version to be published. FZB - interpretation of data. Both authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Ethics approval and consent to participate</title>
<p>This manuscript is a retrospective case report that does not require ethics committee approval at our institution. Consent was considered not required because the cases reported here were anonymous and de-identified.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hudgins</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities</article-title>
<source/>Genet Med
          <year>2010</year>
<volume>12</volume>
<fpage>742</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181f8baad</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Aradhya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Crolla</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Faucett</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Feuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kaminsky</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Kok</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Krantz</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ostell</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Spinner</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Stavropoulos</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Tepperberg</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Thorland</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Vermeesch</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Waggoner</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<fpage>749</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Doccini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bernardini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Loddo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Capalbo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Filippi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Carey</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features</article-title>
<source/>Eur. J. Paediatr. Neurol.
          <year>2013</year>
<volume>17</volume>
<fpage>589</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2013.04.010</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kearney</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Thorland</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Quintero-Rivera</surname>
<given-names>F</given-names>
</name>
<name>
<surname>South</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants</article-title>
<source/>Genet Med
          <year>2011</year>
<volume>13</volume>
<fpage>680</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3182217a3a</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willatt</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Clarkson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Simonic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Docherty</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ogilvie</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Novel deletion variants of 9q13-q21.12 and classical euchromatic variants of 9q12/qh involve deletion, duplication and triplication of large tracts of segmentally duplicated pericentromeric euchromatin</article-title>
<source/>Eur J Hum Genet
          <year>2007</year>
<volume>15</volume>
<fpage>45</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201720</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosyakova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grigorian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liehr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Manvelyan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Simonyan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mkrtchyan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aroutiounian</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Polityko</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Kulpanovich</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Egorova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jaroshevich</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Frolova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shorokh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Naumchik</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Volleth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schreyer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nelle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stumm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wegner</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Reising-Ackermann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Merkas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brecevic</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kreskowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weise</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sazci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cioffi Mde</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ergul</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Heteromorphic variants of chromosome 9</article-title>
<source/>Mol Cytogenet
          <year>2013</year>
<volume>6</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1186/1755-8166-6-14</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joseph-George</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Fahey</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Chitayat</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Winsor</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Euchromatic 9q13-q21 duplication variants are tandem segmental amplifications of sequence reciprocal to 9q13-q21 deletions</article-title>
<source/>J Med Genet
          <year>2011</year>
<volume>48</volume>
<fpage>317</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2010.085662</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Giacomo</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Cesarano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bukvic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Manisali</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guanti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Susca</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Duplication of 9 p 11.2–p13.1: a benign cytogenetic variant</article-title>
<source/>Prenat Diagn
          <year>2004</year>
<volume>24</volume>
<fpage>619</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1002/pd.931</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecce</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Murdolo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Steindl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cupelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zollino</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The euchromatic 9p + polymorphism is a locus-specific amplification caused by repeated copies of a small DNA segment mapping within 9p12</article-title>
<source/>Hum Genet
          <year>2006</year>
<volume>118</volume>
<fpage>760</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-005-0085-x</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrell</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Siegel-Bartelt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Teshima</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Patients with deletions of 9q22q34 do not define a syndrome: three case reports and a literature review</article-title>
<source/>Clin Genet
          <year>1991</year>
<volume>40</volume>
<fpage>207</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.1991.tb03078.x</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Schinzel</surname>
<given-names>A</given-names>
</name>
</person-group>
<source/>Catalogue of unbalanced chromosome aberrations in man
          <year>2001</year>
<publisher-loc>New York</publisher-loc>
<publisher-name>Walter de Gruyter</publisher-name>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3-- &gt; q31.3) associated with Gorlin syndrome</article-title>
<source/>Prenat Diagn
          <year>2006</year>
<volume>26</volume>
<fpage>725</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/pd.1496</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Midro</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Panasiuk</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tumer</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Silahtaroglu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Zemanova</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Stasiewicz-Jarocka</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hubert</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tarasow</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Famulski</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zadrozna-Tolwinska</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wasilewska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kirchhoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kalscheuer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Michalova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Interstitial deletion 9q22.32-q33.2 associated with additional familial translocation t(9;17)(q34.11;p11.2) in a patient with Gorlin-Goltz syndrome and features of Nail-Patella syndrome</article-title>
<source/>Am J Med Genet A
          <year>2004</year>
<volume>124A</volume>
<fpage>179</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.20367</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boonen</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kreiborg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kalscheuer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Brondum-Nielsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tumer</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Delineation of an interstitial 9q22 deletion in basal cell nevus syndrome</article-title>
<source/>Am J Med Genet A
          <year>2005</year>
<volume>132A</volume>
<fpage>324</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.30422</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maloney</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Taborda</surname>
<given-names>F</given-names>
</name>
<name>
<surname>do C Rodriguez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bateman</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Another family with a euchromatic duplication variant of 9q13-q21.1 derived from segmentally duplicated pericentromeric euchromatin</article-title>
<source/>Cytogenet Genome Res
          <year>2013</year>
<volume>141</volume>
<fpage>64</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1159/000350870</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>An extra band in human 9qh + chromosomes</article-title>
<source/>Hum Genet
          <year>1978</year>
<volume>43</volume>
<fpage>259</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1007/BF00278832</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Christ</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Neilson</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Familial 9q22.3 microduplication spanning PTCH1 causes short stature syndrome with mild intellectual disability and dysmorphic features</article-title>
<source/>Am J Med Genet A
          <year>2011</year>
<volume>155A</volume>
<fpage>1384</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33959</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Derwinska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Smyk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>PTCH1 duplication in a family with microcephaly and mild developmental delay</article-title>
<source/>Eur J Hum Genet
          <year>2009</year>
<volume>17</volume>
<fpage>267</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2008.176</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kajii</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Murano</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Inverted insertion (9)(q34.3q22.3q21.2) and its recombination product: duplication 9q21.2q22.3. <italic>Jinrui idengaku zasshi</italic></article-title>
<source/>Jpn J Hum Genet
          <year>1987</year>
<volume>32</volume>
<fpage>45</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1007/BF01876527</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stark</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Behrsin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Savarirayan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>SNP microarray abnormalities in a cohort of 28 infants with congenital diaphragmatic hernia</article-title>
<source/>Am J Med Genet A
          <year>2015</year>
<volume>167A</volume>
<fpage>2319</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37177</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>